Recombination and fork progression in bacteriophage T4
噬菌体 T4 的重组和分叉进展
基本信息
- 批准号:6931049
- 负责人:
- 金额:$ 34.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2008-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The repair of DNA lesions such as double strand breaks (DSBs) is crucial to the stability of the genome, and we are proposing to study two processes that are fundamental to the prevention and repair of DSBs in all cells. The first is recombination-dependent replication (RDR) that is now recognized as a central mechanism in DNA metabolism that operates in many DNA repair scenarios. The second process is replication fork progression and the rescue of stalled forks. Stalled forks can lead to DSBs, and they need to be rapidly dealt with in the cell. We are interested in the underlying mechanisms that operate in these two processes, and will therefore study them in a very simple, well characterized organism, namely bacteriophage T4. Phage T4 is an ideal system for the multidisciplinary approach that we have designed, and there are many similarities between T4 and eukaryotic proteins. Defects in repair mechanisms lead to the accumulation of mutations that eventually result in cancer, and the proposed studies in T4 are therefore directly relevant to human disease. Five T4 proteins will be studied, UvsX, UvsY, UvsW, Dda and MotA. The recombinatorial proteins UvsX and UvsY mediate the T4 homologous recombination reaction that is required for RDR. UvsW and Dda are helicases that translocate and/or unwind branched nucleic acid structures and have important roles in RDR and replication fork progression. Defects in helicases such as Bloom and Werner are known to cause cancer in humans, and there is evidence that UvsW and Dda may be functionally homologous to these molecules. Finally, structural studies suggest that the T4 transcription factor MotA binds DNA in a novel fashion that is shared by UvsW. The mechanisms of these five proteins will be studied at the molecular level by a coordinated approach involving X-ray crystallography and NMR spectroscopy to study their structures, in vitro methods to study their individual functions and interactions, and in vivo methods to understand their biological roles. A considerable body of preliminary data have been obtained for this project that includes two high resolution structures, crystals, purified proteins and functional information from T4 mutants. The P.I. will direct the structural studies, and the co-P.I. will direct the in vivo studies. The in vitro analyses will be performed in both laboratories as appropriate.
描述(由申请人提供):DNA损伤(如双链断裂(DSB))的修复对基因组的稳定性至关重要,我们建议研究对所有细胞中DSB的预防和修复至关重要的两个过程。 第一个是重组依赖性复制(RDR),现在被认为是DNA代谢的中心机制,在许多DNA修复方案中发挥作用。 第二个过程是复制分叉的进展和对停滞分叉的拯救。 停滞的分叉可能导致DSB,它们需要在单元中快速处理。 我们对这两个过程中的潜在机制感兴趣,因此将在一个非常简单,特征良好的生物体中研究它们,即噬菌体T4。噬菌体T4是我们设计的多学科方法的理想系统,T4和真核蛋白质之间有许多相似之处。 修复机制的缺陷会导致突变的积累,最终导致癌症,因此在T4中的拟议研究与人类疾病直接相关。 将研究五种T4蛋白,UvsX、UvsY、UvsW、Dda和MotA。 重组蛋白UvsX和UvsY介导RDR所需的T4同源重组反应。UvsW和Dda是转位和/或解旋分支核酸结构的解旋酶,并且在RDR和复制叉进展中具有重要作用。 已知Bloom和Werner等解旋酶的缺陷会导致人类癌症,并且有证据表明UvsW和Dda可能与这些分子在功能上同源。 最后,结构研究表明,T4转录因子MotA以一种新的方式结合DNA,这种方式是UvsW所共有的。 这五种蛋白质的机制将在分子水平上通过协调的方法进行研究,包括X射线晶体学和NMR光谱学研究它们的结构,体外方法研究它们的个体功能和相互作用,以及体内方法了解它们的生物学作用。 该项目已经获得了相当多的初步数据,包括两个高分辨率结构,晶体,纯化的蛋白质和T4突变体的功能信息。 私家侦探将指导结构研究,和共同P. I.将指导体内研究。体外分析将在两个实验室进行(如适用)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN W WHITE其他文献
STEPHEN W WHITE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN W WHITE', 18)}}的其他基金
Training in the Design and Development of Infectious Disease Therapeutics
传染病治疗药物设计和开发培训
- 批准号:
10270490 - 财政年份:2015
- 资助金额:
$ 34.62万 - 项目类别:
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
新型 DHPS 抑制剂探索催化机制
- 批准号:
7132164 - 财政年份:2006
- 资助金额:
$ 34.62万 - 项目类别:
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
新型 DHPS 抑制剂探索催化机制
- 批准号:
7236066 - 财政年份:2006
- 资助金额:
$ 34.62万 - 项目类别:
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
新型 DHPS 抑制剂探索催化机制
- 批准号:
7617662 - 财政年份:2006
- 资助金额:
$ 34.62万 - 项目类别:
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
新型 DHPS 抑制剂探索催化机制
- 批准号:
7848340 - 财政年份:2006
- 资助金额:
$ 34.62万 - 项目类别:
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
新型 DHPS 抑制剂探索催化机制
- 批准号:
7422359 - 财政年份:2006
- 资助金额:
$ 34.62万 - 项目类别:
Development of DHPS as a Bioterrorism Therapeutic Target
DHPS 作为生物恐怖主义治疗目标的发展
- 批准号:
6915228 - 财政年份:2004
- 资助金额:
$ 34.62万 - 项目类别:
Development of DHPS as a Bioterrorism Therapeutic Target
DHPS 作为生物恐怖主义治疗目标的发展
- 批准号:
6809822 - 财政年份:2004
- 资助金额:
$ 34.62万 - 项目类别:
Recombination and fork progression in bacteriophage T4
噬菌体 T4 的重组和分叉进展
- 批准号:
7099478 - 财政年份:2004
- 资助金额:
$ 34.62万 - 项目类别:
Recombination and fork progression in bacteriophage T4
噬菌体 T4 的重组和分叉进展
- 批准号:
7267776 - 财政年份:2004
- 资助金额:
$ 34.62万 - 项目类别:
相似海外基金
Elucidation of the life-sustaining mechanism of hyperthermophilic archaea without DNA replication origin
阐明无DNA复制起点的超嗜热古菌的生命维持机制
- 批准号:
19K22289 - 财政年份:2019
- 资助金额:
$ 34.62万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Identification of the DNA replication origin in Arabidopsis
拟南芥DNA复制起点的鉴定
- 批准号:
17K19250 - 财政年份:2017
- 资助金额:
$ 34.62万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Genome-wide identification of DNA replication origin sequences in human cells
人类细胞 DNA 复制起点序列的全基因组鉴定
- 批准号:
16K12595 - 财政年份:2016
- 资助金额:
$ 34.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8457662 - 财政年份:2013
- 资助金额:
$ 34.62万 - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8706908 - 财政年份:2013
- 资助金额:
$ 34.62万 - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8665806 - 财政年份:2013
- 资助金额:
$ 34.62万 - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8824650 - 财政年份:2013
- 资助金额:
$ 34.62万 - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8829782 - 财政年份:2013
- 资助金额:
$ 34.62万 - 项目类别:
Diversity Supplement: Post-Translational Regulation of DNA Replication Origin Licensing in Human Cells
多样性补充:人类细胞中 DNA 复制起点许可的翻译后调控
- 批准号:
10120875 - 财政年份:2013
- 资助金额:
$ 34.62万 - 项目类别:
Post-translational regulation of DNA replication origin licensing in human cells
人类细胞 DNA 复制起点许可的翻译后调控
- 批准号:
10093060 - 财政年份:2013
- 资助金额:
$ 34.62万 - 项目类别: